Pamela S. Wirth

964 total citations · 1 hit paper
8 papers, 660 citations indexed

About

Pamela S. Wirth is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Pamela S. Wirth has authored 8 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Pamela S. Wirth's work include Pancreatic and Hepatic Oncology Research (2 papers), Head and Neck Cancer Studies (2 papers) and Cancer-related molecular mechanisms research (2 papers). Pamela S. Wirth is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Head and Neck Cancer Studies (2 papers) and Cancer-related molecular mechanisms research (2 papers). Pamela S. Wirth collaborates with scholars based in United States, Netherlands and Canada. Pamela S. Wirth's co-authors include Thomas H. Weller, John M. Craig, Wendell G. Yarbrough, Judith Romero–Gallo, Anna Chytil, Agnieszka E. Gorska, Swati Biswas, Kay Washington, Harold L. Moses and Christine H. Chung and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Pamela S. Wirth

8 papers receiving 588 citations

Hit Papers

Isolation of Intranuclear... 1957 2026 1980 2003 1957 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela S. Wirth United States 7 228 226 188 98 74 8 660
Tong‐Min Wang China 15 91 0.4× 253 1.1× 167 0.9× 114 1.2× 69 0.9× 45 809
Ryuichi Nakashima Japan 13 244 1.1× 212 0.9× 135 0.7× 124 1.3× 16 0.2× 18 606
Kerstin Pischinger Austria 11 225 1.0× 265 1.2× 174 0.9× 75 0.8× 12 0.2× 22 601
Anna Zhou United States 9 82 0.4× 378 1.7× 159 0.8× 42 0.4× 86 1.2× 26 873
Kirti Srivastava India 14 196 0.9× 103 0.5× 117 0.6× 74 0.8× 83 1.1× 61 601
Hsin‐Pai Li Taiwan 15 87 0.4× 409 1.8× 295 1.6× 177 1.8× 67 0.9× 29 943
Fai Ng Hong Kong 9 163 0.7× 119 0.5× 113 0.6× 39 0.4× 32 0.4× 13 411
Wenhu Chen China 17 248 1.1× 261 1.2× 201 1.1× 209 2.1× 15 0.2× 66 1.3k
Miriam Mints Sweden 18 324 1.4× 285 1.3× 124 0.7× 95 1.0× 8 0.1× 52 967
Fabio Bottari Italy 15 328 1.4× 185 0.8× 85 0.5× 82 0.8× 11 0.1× 38 629

Countries citing papers authored by Pamela S. Wirth

Since Specialization
Citations

This map shows the geographic impact of Pamela S. Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela S. Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela S. Wirth more than expected).

Fields of papers citing papers by Pamela S. Wirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela S. Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela S. Wirth. The network helps show where Pamela S. Wirth may publish in the future.

Co-authorship network of co-authors of Pamela S. Wirth

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela S. Wirth. A scholar is included among the top collaborators of Pamela S. Wirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela S. Wirth. Pamela S. Wirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gilbert, Jill, Barbara A. Murphy, Mary S. Dietrich, et al.. (2011). Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Cancer. 118(4). 1007–1013. 14 indexed citations
2.
Hatakeyama, Hiromitsu, Haixia Cheng, Pamela S. Wirth, et al.. (2010). Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma. PLoS ONE. 5(9). e12702–e12702. 125 indexed citations
3.
Cohen, Seth M., Amy Evjen, Jonathan H. Law, et al.. (2009). Human papillomavirus in early laryngeal carcinoma. The Laryngoscope. 119(8). 1531–1537. 68 indexed citations
4.
Law, Jonathan H., Amy S. Whigham, Pamela S. Wirth, et al.. (2009). Human‐in‐mouse modeling of primary head and neck squamous cell carcinoma. The Laryngoscope. 119(12). 2315–2323. 4 indexed citations
5.
Chaurand, Pierre, Joey C. Latham, Kirk B. Lane, et al.. (2008). Imaging Mass Spectrometry of Intact Proteins from Alcohol-Preserved Tissue Specimens: Bypassing Formalin Fixation. Journal of Proteome Research. 7(8). 3543–3555. 60 indexed citations
6.
Welch, Derek C., Pamela S. Wirth, James R. Goldenring, et al.. (2006). Gastric Graft-Versus-Host Disease Revisited. The American Journal of Surgical Pathology. 30(4). 444–449. 28 indexed citations
7.
Biswas, Swati, Anna Chytil, Kay Washington, et al.. (2004). Transforming Growth Factor β Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer. Cancer Research. 64(14). 4687–4692. 124 indexed citations
8.
Weller, Thomas H., et al.. (1957). Isolation of Intranuclear Inclusion Producing Agents from Infants with Illnesses Resembling Cytomegalic Inclusion Disease.. Experimental Biology and Medicine. 94(1). 4–12. 237 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026